Carbocysteine

Carbocysteine

SCHEMBL20854

N[C@@H](CSCC(=O)O)C(=O)O

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BHMT Q93088 6/20 0.59
ARG1 P05089 1/20 0.53
ARG2 P78540 1/20 0.53
CYP2D6 P10635 2/20 0.50
HIF1A Q16665 1/20 0.50
NOS2 P35228 3/20 0.47
NOS1 P29475 2/20 0.47
NOS3 P29474 1/20 0.47
GRM8 O00222 1/20 0.44
GRM6 O15303 1/20 0.44
GRIN2D O15399 1/20 0.44
GRIN3B O60391 1/20 0.44
GSR P00390 1/20 0.44
CYP1A2 P05177 1/20 0.44
GRIK1 P39086 1/20 0.44
GRM5 P41594 1/20 0.44
GRIA1 P42261 1/20 0.44
GRIA2 P42262 1/20 0.44
GRIA3 P42263 1/20 0.44
SLC1A3 P43003 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbocysteine SCHEMBL6762355 1.00 BHMT (0.59) BHMTARG1ARG2CYP2D6HIF1A
Carbocysteine SCHEMBL9236855 1.00 BHMT (0.59) BHMTARG1ARG2CYP2D6HIF1A
Carbocysteine SCHEMBL69149 1.00 BHMT (0.59) BHMTARG1ARG2CYP2D6HIF1A
Carbocysteine SCHEMBL19614508 0.98 BHMT (0.57) BHMTARG1ARG2CYP2D6HIF1A
Carbocysteine SCHEMBL19614507 0.98 BHMT (0.57) BHMTARG1ARG2CYP2D6HIF1A
Carbocysteine SCHEMBL19614516 0.98 BHMT (0.57) BHMTARG1ARG2CYP2D6HIF1A
Carbocysteine SCHEMBL19614546 0.98 BHMT (0.57) BHMTARG1ARG2CYP2D6HIF1A
Carbocysteine SCHEMBL15545269 0.98 BHMT (0.57) BHMTARG1ARG2CYP2D6HIF1A
Carbocysteine SCHEMBL19614495 0.98 BHMT (0.57) BHMTARG1ARG2CYP2D6HIF1A
Carbocysteine SCHEMBL19614544 0.98 BHMT (0.57) BHMTARG1ARG2CYP2D6HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 7037 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4255391-B1 LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION METRIOPHARM AG (CH) 2026-05-06 EP claimed
EP-4434588-B1 AEROSOL DELIVERY DEVICE PARI PHARMA GMBH (DE) 2026-04-08 EP claimed
US-20260034207-A1 VACCINE COMPOSITION FOR SUBLINGUAL ADMINISTRATION EPS INNOVATIVE MEDICINE (JAPAN) CO., LTD. (JP) 2026-02-05 US claimed
EP-4626466-A1 COMPOSITIONS AND METHODS FOR TREATING FUNGAL INFECTIONS Mucpharm Pty Ltd (AU) 2025-10-08 EP claimed
EP-4610352-A1 SERINE PROTEASE FOR SELECTIVELY DEGRADING MUCIN AND USE THEREOF Sun, Zhenglong (CN) 2025-09-03 EP claimed
US-12370140-B2 Micelle for solubilizing a sparingly water-soluble ingredient and solution comprising the same TEIKA PHARMACEUTICAL CO., LTD. (JP) 2025-07-29 US claimed
US-20250197837-A1 SERINE PROTEASE FOR SELECTIVELY DEGRADING MUCINS AND USE THEREOF SUN, Zhenglong (CN) 2025-06-19 US claimed
WO-2025128536-A1 DISULFIDE ISOFORM MODULATION GENENTECH, INC. (US) 2025-06-19 WO claimed
US-20250161255-A1 NEW THERAPY AND PREVENTION FOR SUPPRESSING AGING-RELATED DISORDERS INCLUDING SARCOPENIA ASAGI LABS (JP) 2025-05-22 US claimed
EP-4552645-A1 VACCINE COMPOSITION FOR SUBLINGUAL ADMINISTRATION EPS INNOVATIVE MEDICINE (JAPAN) CO., LTD. (JP) 2025-05-14 EP claimed
US-4411840-A Process for the resolution of the racemate S-(carboxymethyl)-(RS)-cysteine (B) DEGUSSA AKTIENGESELLSCHAFT (DE) 1983-10-25 US claimed
EP-0090087-A1 Process for the production of S-(carboxymethyl)-R-cysteine and S-(carboxymethyl)-S-cysteine Degussa Aktiengesellschaft (DE) 1983-10-05 EP claimed
EP-0088998-A1 Process for racemising optically active S-(carboxy-methyl) cysteine Degussa Aktiengesellschaft (DE) 1983-09-21 EP claimed
EP-0073054-A1 Process for the resolution of the racemate (1RS,2SR)-2-amino-1-phenyl-propan-1-ol Degussa Aktiengesellschaft (DE) 1983-03-02 EP claimed
EP-0073053-A1 Process for the resolution of the racemate S-(carboxymethyl)-(RS)-cysteine (B) Degussa Aktiengesellschaft (DE) 1983-03-02 EP claimed
EP-0073052-A1 Process for the resolution of the racemate S-(carboxymethyl)-(RS)-cysteine (A) Degussa Aktiengesellschaft (DE) 1983-03-02 EP claimed
US-4288433-A THIOETHER AND A XANTHINE DERIVATIVE L'OREAL (FR) 1981-09-08 US claimed
US-4129593-A Process for the production of high purity S-carboxymethyl-L-cysteine DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) 1978-12-12 US claimed
US-4071517-A Soluble salts containing sulphur DUFOUR CLAUDE 1978-01-31 US claimed
US-RE29256-E Digestive pharmaceutical composition comprising S-carboxymethyl cysteine for reducing viscosity of respiratory tract secretions, and method of treating therewith RECHERCHE PHARMACEUTIQUES ET SCIENTIFIQUES (FR) 1977-06-07 US claimed